Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Rabies Virus Antigen" patented technology

Detection of Rabies Virus Antigen in Dog Saliva Using a Latex Agglutination Test S. Kasempimolporn , * W. Saengseesom , B. Lumlertdacha , and V. Sitprija Queen Saovabha Memorial Institute (World Health Organization Collaborating Center for Research on Rabies Pathogenesis and Prevention), Thai Red Cross Society, Bangkok, Thailand

Porcine circovirus II type-porcine pseudorabies double-combination vaccine, and preparation methods and application thereof

The invention relates to a porcine circovirus II type-porcine pseudorabies double-combination vaccine which is characterized by including at least one porcine circovirus II type antigen and at least one porcine pseudorabies virus antigen. The invention also relates to two preparation methods of the double-combination vaccine. One method comprises the steps: inactivating the porcine circovirus II type to obtain a porcine circovirus II type inactivated vaccine; and mixing the porcine pseudorabies virus antigen with a freeze-drying protective agent to obtain a porcine pseudorabies freeze-drying living vaccine, and then dissolving the porcine pseudorabies freeze-drying living vaccine with the inactivated vaccine as a diluent to obtain the porcine circovirus II type-porcine pseudorabies double-combination vaccine composition. The other method comprises the steps: mixing the porcine circovirus II type antigen with the porcine pseudorabies virus antigen in proportion, and then mixing with the freeze-drying protective agent to obtain the double-combination freeze-drying vaccine. With use of the double-combination vaccine, the cold chain operating cost can be greatly reduced; and the combination vaccine has a synergistic role in the immune effect on the porcine pseudorabies virus antigen, and does not affect the immune effect of the porcine circovirus antigen.
Owner:PU LIKE BIO ENG

Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper

The invention discloses a piece of test paper for colloidal gold immunochromatograohic assay of an IgG (immunoglobulin G) antibody of dog anti-rabies virus and a preparation method of the test paper. The test paper comprises a sample absorbing region, a gold-labeled probe region, a solid-phase antibody region, a water absorbing region and a supporting plate, wherein the sample absorbing region, the gold-labeled probe region, the solid-phase antibody region and the water absorbing region are laid on the supporting plate and are partially overlapped in sequence; the sample absorbing region is coated with rabies virus antigen; the gold-labeled probe region is coated with a gold-labeled probe 1 and a gold-labeled probe 2 which are a monoclonal antibody of the colloidal gold-labeled rabies virus and rabbit IgG respectively; the solid-phase antibody region has a control line C1 (coated with a goat anti-rabbit IgG antibody), a testing line T (coated with a goat anti-dog IgG antibody), a control line C2 (coated with a goat anti-rabbit IgG antibody) and a control line C3 (coated with a goat anti-mouse IgG antibody). The test paper disclosed by the invention has the advantages that the test is fast, the accuracy rate is high, the specificity is strong, the test paper is simple and convenient to carry and operate, and the level of the rabies virus antibody is judged according to the color depths of the control lines.
Owner:WUHAN CHOPPER BIOLOGY

Porcine parvovirus-porcine pseudorabies combined inactivated vaccine, and preparation method and application thereof

The invention discloses a porcine parvovirus-porcine pseudorabies combined inactivated vaccine, and a preparation method and an application thereof. The preparation method comprises the following steps: respectively inactivating a porcine parvovirus liquid and a porcine pseudorabies liquid with pyrrole to obtain a porcine parvovirus antigen and a porcine pseudorabies antigen, and mixing the porcine parvovirus antigen and the porcine pseudorabies antigen with an oil phase adjuvant to prepare the combined inactivated vaccine. No immunosuppression exists between the two antigen components in the combined inactivated vaccine, the combined inactivated vaccine prepared from the porcine parvovirus antigen and the porcine pseudorabies antigen according to a volume ratio of 2:3 has better safety and immunoprotection effects than single vaccines, and the porcine parvovirus and the porcine pseudorabies can be substantially immunoprotected through one-shot syringe injection. The porcine parvovirus-porcine pseudorabies combined inactivated vaccine has the advantages of good safety, avoiding of untoward effects of multi-time immunoprophylaxis, reduction of the immunization cost, and use convenience, and can be applied in effective prevention of the porcine parvovirus and the porcine pseudorabies.
Owner:哈药集团生物疫苗有限公司

Method for producing rabies virus antigens for animals at a large scale

The invention discloses a method for producing rabies virus antigens for animals at a large scale, which produces the rabies virus antigens at a large scale by utilizing a bioreactor by a cell microcarrier suspension culture system. The method comprises the following steps: inoculating cells for preparing the antigens into a carrier tank containing a culture solution and microcarriers to enable the cells to be attached to the microcarriers; in a proper culture environment, enabling the cells to grow on the microcarriers until the quantity of the cells is 5-40 times more than inoculum density; making rabies viruses into a virus suspension, and enabling the virus suspension to be adsorbed on the cells; culturing the viruses in the proper culture environment by using a cell maintenance culture solution; continuously culturing for 3-5 days and then harvesting a virus solution for the first time, wherein a semicontinuous process is adopted and the ratio of a changed solution is 50 percent; continue culturing for 9-11 days, and harvesting the changed solution once every 24 hours; mixing the harvested virus solution with the virus solution of the bioreactor; and carrying out freeze thawing at the temperature of -20 DEG C and inactivation purification to obtain the rabies virus antigens. The method has large production scale, high single-scale yield and relatively low production cost.
Owner:PU LIKE BIO ENG

Pseudorabies/porcine parvovirus infection combined inactivate vaccine and suspension culture preparation method

InactiveCN108421037AHigh antigen contentLarge batches of antigensViral antigen ingredientsInactivation/attenuationAdjuvantPorcine parvovirus antigen
The invention belongs to the technical field of veterinary biological products and particularly relates to a pseudorabies/porcine parvovirus infection combined inactivate vaccine and a suspension culture preparation method. The preparation method comprises the following steps: preparing a pseudorabies virus suspension culture antigen and a porcine parvovirus infection virus suspension culture antigen; proportionally mixing the inactivated pseudorabies virus and porcine parvovirus infection virus antigen solutions, and then adding an adjuvant to fully emulsify to obtain the pseudorabies/porcineparvovirus infection combined inactivate vaccine. The suspension culture processes of the pseudorabies virus antigen solution and the porcine parvovirus infection virus antigen solution are established, the virus antigen solutions prepared through the suspension culture process have the advantages of high antigen content, large batch of the antigen and stable batch, the preparation method greatlyreduces the use of manpower, the occupied area and space of a culture system is reduced, and the production cost of an enterprise is lowered; meanwhile, the pseudorabies/porcine parvovirus infectioncombined inactivate vaccine is used, two viruses are prevented through one syringe, the immunity times of an animal are reduced, the stress times of the animal are reduced, and the production cost ofthe vaccine and the culture cost of a farmer are greatly reduced.
Owner:WUHAN KEQIAN BIOLOGY CO LTD

Method for preparing rabies virus antigen by chloroplast

The invention provides a method for preparing a rabies virus antigen by chloroplast, comprising the following steps: (1) constructing a chlamydomonas chloroplast expression vector of rabies virus antigen gene; (2) screening the constructed expression vector transgenosis chlamydomonas to obtain transgenosis chlamydomonas; and (3) culturing transgenosis chlamydomonas to express the rabies virus antigen gene in chlamydomonas to obtain the rabies virus antigen. In the method of the invention, a chlamydomonas chloroplast expression system is utilized to produce rabies virus antigens safely and efficiently in a chlamydomonas bioreactor, the expressed protein has high specificity and good immunity effect, and can not produce non-purposive immunoreaction. The cost of the method of the invention is significantly lower than that of a traditional method for preparing the rabies virus antigen, the method has no need of investing and building factories and no generation of three wastes (waste gas, waste water and industrial residue), and the consumption of electric power, water resource and other resources is extremely low. The antigen prepared by the method of the invention has very high security and no need of purification, and can be directly used as animal supplementary feed, thus having treatment effect.
Owner:THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI

Rabies virus antibody quantitative detection kit as well as preparation method and detection method thereof

The invention discloses a rabies virus antibody quantitative detection kit as well as a preparation method and a detection method thereof, belongs to the technical field of antibody detection kits, and solves the problems that the antibody detection accuracy is not high enough and potential safety hazards exist in the prior art. The kit comprises an immunochromatographic detection test strip and asample diluent, the immunochromatographic detection test strip sequentially comprises a sample pad coated with a rabies virus antigen, a marker pad coated with a monoclonal antibody of the rabies virus antigen, a nitrocellulose membrane coated with a detection line and a quality control line and a water absorption pad from one end to the other end, and the sample pad, the marker pad, the nitrocellulose membrane and the water absorption pad are mutually stacked and attached to the upper surface of a back plate. According to the invention, the rabies virus antibody in blood is detected by adopting a competition method, and real antibody numerical values in a blood sample can be directly displayed according to a standard curve in combination with strip reading equipment, so that the detection accuracy and sensitivity are improved.
Owner:CHANGCHUN SR BIOLOGICAL TECH

Rabies virus antibody colloidal gold detection test strip for human and livestock joint detection and preparation method thereof

The invention discloses a rabies virus antibody colloidal gold detection test strip for human and livestock joint detection and a preparation method of the rabies virus antibody colloidal gold detection test strip. The rabies virus antibody colloidal gold detection test strip comprises a colloidal gold labeled binding area and a detection area, wherein a detection line and a quality control line are arranged on the detection area, rabies virus antigens labeled by colloidal gold and albumen protein gold particles labeled by colloidal gold are wrapped by the colloidal gold labeled binding area, staphylococcus albumins are wrapped by the detection line, and ovalbumin antibodies are wrapped by the quality control line. According to the rabies virus antibody colloidal gold detection test strip, the detection cost can be reduced, the detection sensitivity can be improved, false positive can be avoided, and the human and livestock joint detection of rabies virus antibodies is achieved. Furthermore, the instability problem appearing when monoclonal antibodies or polyclonal antibodies are used as the quality control line can be effectively solved through the quality control line, and the rabies virus antibody colloidal gold detection test strip has a great significance in large-batch sample detection, field application and immunized human self-detection and has very large market development potentials.
Owner:HUAZHONG AGRI UNIV

Preparation method for living-vector vaccine against rabies, product thereof and application thereof

The invention discloses a preparation method for a living-vector vaccine against rabies, a product thereof and application thereof. The method comprises the following steps: 1, designing primers and amplifying a rabies virus antigen protein gene G and a bacterial flagellin gene FIjB or FIiC; 2, inserting the antigen protein gene G and the gene FIjB or FIiC between a specific promoter and a specific terminator of a replication-competent defective adenovirus shuttle vector so as to construct an adenovirus shuttle vector containing a gene G-FIjB or a gene G-FIiC; 3, subjecting the obtained recombinant replication-competent defective adenovirus shuttle vector and an adenovirus skeleton vector to homologous recombination so as to obtain recombinant adenovirus plasmids; and 4, producing recombinant adenoviruses with a uniform genomic structure from the recombinant adenovirus plasmids. Moreover, the invention also provides the living-vector vaccine against rabies prepared by using the method. Compared with the prior art, the living-vector vaccine against rabies prepared in the invention is safer and more effective, is short in a preparation period and has good application prospects in the field of prevention or treatment of rabies.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Rabies virus antibody test paper, preparation method thereof and detection method thereof

The invention discloses rabies virus antibody test paper and a preparation method thereof and a detection method thereof, which belong to the technical field of antibody test paper. The problems of false positive risk and safety hazard in the prior art are solved. The test paper comprises, from one end to the other end, a sample pad which coats a rabies virus antigen, a gold standard pad which coats a monoclonal antibody against the rabies virus antigen, a nitrocellulose membrane which coats a detection line and a quality control line, and an absorbent pad, wherein the sample pad, the gold standard pad, the nitrocellulose membrane and the absorbent pad overlap each other and are attached to the upper surface of a backboard. The rabies virus antigen coated by the sample pad is rabies virus-like particles. According to the invention, the used labeled antigen is the rabies virus-like particles expressed by insect cells, which avoids false positives; the monoclonal antibody against the rabies virus G protein competes with a neutralizing antibody in the blood to improve the detection accuracy and sensitivity; the virus-like particles are free of nucleic acid components; and biosafety risks produced by the use of whole viruses as marker antigens are eliminated.
Owner:CHANGCHUN SR BIOLOGICAL TECH

Vaccine compound and preparation method and application thereof

The invention provides a method for preparing a vaccine compound. The method comprises the steps that 1, liquid containing porcine pseudorabies virus is prepared; 2, by adding a nonionic surfactant ora solution containing the nonionic surfactant into the liquid of the step 1, envelope protein which exists in the porcine pseudorabies virus liquid is solubilized; 3, the nonionic surfactant in the step 2 is removed to obtain an purified porcine pseudorabies virus antigen; 4, the antigen prepared in the step 3 is used for preparing the vaccine compound. The invention further provides the vaccinecompound which is prepared through the preparation method and contains the porcine pseudorabies antigen; according to the vaccine compound, an immunosuppression component is removed, and meanwhile, animmunocompetence component is maintained furthest, so that the vaccine compound has a good protective effect on lung lesion of pigs; when the vaccine compound is used in cooperation with a porcine reproductive and respiratory syndrome live virus antigen, the vaccine compound does not have an inhibiting effect on the porcine reproductive and respiratory syndrome live virus antigen, which shows that the vaccine compound can be used in cooperation with multiple kinds of other antigen components.
Owner:PULIKE BIOLOGICAL ENG INC

Rabies vaccines and applications based on self-assembled ferritin nano-antigen particles and prepared therefrom

The invention discloses a rabies vaccine and application based on self-assembled ferritin nanometer antigen particles and prepared therefrom. In the invention, the rabies virus G antigen protein is fused with the self-assembled ferritin nanoparticle subunit to obtain a fusion protein. In the present invention, the rabies virus G antigen protein is subjected to site mutation, and the soluble expression amount and expression efficiency of the obtained mutant are significantly improved. The present invention utilizes prokaryotic expression system, silkworm and AcMNPV-insect cell eukaryotic expression system to express recombinant protein, or performs gene presentation in vertebrate body by recombinant baculovirus to produce antigen and induce antibody production. The rabies vaccine provided by the present invention displays antigenic proteins on the surface of the ferritin cage structure of Helicobacter pylori, causing broadly neutralizing anti-rabies virus antibodies, improving immune efficacy and expanding the scope of immunity, and has the potential of a universal vaccine with cross-immunity efficacy . The vaccine preparation method of the present invention is safe and convenient, and is suitable for rapid large-scale production.
Owner:THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products